(Post-pandemic Era)-Global Biopharmaceutical Cold Chain Logistics Market (Sales, Revenue, Price, Gross Profit and Competitors Analysis of Major Market) from 2016-2027
- Report Code : XYZ2444412
- Published On: Apr, 2021
- Category : Chemicals & Materials
- Pages : 108
-
As the world continues to deal with COVID-19, economies are moving into recession, under multiple adverse factors, the GDP of European and American countries in the second quarter suffered a historical contraction. At an annualized rate, the US GDP fell by 32.9% month on month, while the overall GDP of the euro zone fell by 12.1%.
Moreover, the economic prospects of Europe and the United States in the third quarter under the epidemic situation are hardly optimistic. The resumption of work and production not only brought economic data back, but also triggered a rebound in the epidemic situation. At present, the United States is still the 'epicenter' of the global epidemic. The total number of confirmed cases has exceeded 4.8 million, and the epidemic situation in some European countries has also rebounded. Affected by this, more than 20 states in the United States have announced the suspension or withdrawal of part of the economic restart plan. Britain and Italy have also decided to extend the state of emergency. The rebound of the epidemic situation has posed considerable risks to the economic prospects of Europe and the United States.
In the second quarter of this year, US GDP shrank by 9.5% on a month on month basis, or 32.9% at an annual rate, the largest decline since the 1940s. Data show that the sharp decline in personal consumption is the main drag on the U.S. GDP growth in the second quarter.
Compared with the United States, Europe's economic contraction in the second quarter was smaller, but it was also the lowest on record, with Germany and France contracting more than 10%. According to the data released by the Federal Bureau of statistics, Germany's GDP fell by 10.1% in the second quarter after adjusting for prices, seasons and working days, the largest decline since the quarterly economic data were available in 1970.
Thanks to the effective control and policy support of the new epidemic, China's economy rebounded sharply in the second quarter. The growth rate of manufacturing industry, which accounted for about 28% of GDP, rebounded sharply to 4.4% from the negative value in the first quarter. Chinese original equipment manufacturers (OEMs) and suppliers are ramping up production. And there are increased investments in digital footprints in manufacturing. OEMs in other parts of the world are offering incentives to drive sales. Research published a report for global Biopharmaceutical Cold Chain Logistics market in this environment.
In terms of revenue, this research report indicated that the global Biopharmaceutical Cold Chain Logistics market was valued at USD XXX million in 2020, and it is expected to reach a value of USD XXX million by 2027, at a CAGR of XX % over the forecast period 2021-2027. Correspondingly, the forecast analysis of Biopharmaceutical Cold Chain Logistics industry comprises of China, USA, Japan, India, Korea and South America, with the production and revenue data in each of the sub-segments.
The Agility Logistics aims at producing XX K Units Biopharmaceutical Cold Chain Logistics in 2020, with XX % production to take place in global market, Deutsche Post accounts for a volume share of XX %.
Regional Segmentation (Value; Revenue, USD Million, 2026-2027) of Biopharmaceutical Cold Chain Logistics Market Include by
China
EU
USA
Japan
India
Southeast Asia
South America
Competitive Analysis; Who are the Major Players in Biopharmaceutical Cold Chain Logistics Market
Agility Logistics
Deutsche Post
FedEx
JWD InfoLogistics Public
Kerry Logistics Network
Major Type of Biopharmaceutical Cold Chain Logistics Covered in Research report:
Warehousing and VAS
Transportation
Application Segments Covered in Research Market
Generic Drugs
Branded Drugs
Application 3
For any other requirements, please feel free to contact us and we will provide you customized report.
-
With tables and figures helping analyze worldwide (Post pandemic Era) Global Biopharmaceutical Cold Chain Logistics market, this research provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.
Global Biopharmaceutical Cold Chain Logistics Market Analysis 2021, With Top Companies, Production, Revenue, Consumption, Price and Growth Rate
1 Market Scope1.1 Product Details and Introduction
1.1.1 Warehousing and VAS -Product Introduction and Major Manufacturers
1.1.2 Transportation -Product Introduction and Major Manufacturers1.2 Market Snapshot
1.2.1 Major Companies Overview
1.2.2 Market Concentration
1.2.3 Six-Year Compound Annual Growth Rate (CAGR)
2 Global Biopharmaceutical Cold Chain Logistics Market Assessment, by Segmentation2.1 Type Breakdown Estimates & Forecast, Sales Volume (2026-2027)
2.2 Type Breakdown Estimates & Forecast, Sales Value (2026-2027)
2.3 Application Breakdown Estimates & Forecast, by Application (2026-2027)
3 Regional Market Analysis3.1 China Biopharmaceutical Cold Chain Logistics Market
3.1.1 Top Companies leading Biopharmaceutical Cold Chain Logistics Development in China (2016-2021)
3.1.2 Sales Value of Major Company in China Market (2016-2021)
3.1.3 China Biopharmaceutical Cold Chain Logistics Price (USD/Unit), by Type (2019-2020)
3.1.4 Sales in China Market, by Type (2026-2027)3.2 EU Biopharmaceutical Cold Chain Logistics Market
3.2.1 Top Companies leading Biopharmaceutical Cold Chain Logistics Development in EU (2016-2021)
3.2.2 Sales Value of Major Company in EU Market (2016-2021)
3.2.3 EU Biopharmaceutical Cold Chain Logistics Price (USD/Unit), by Type (2019-2020)
3.2.4 Sales in EU Market, by Type (2026-2027)3.3 USA Biopharmaceutical Cold Chain Logistics Market
3.3.1 Top Companies leading Biopharmaceutical Cold Chain Logistics Development in USA (2016-2021)
3.3.2 Sales Value of Major Company in USA Market (2016-2021)
3.3.3 USA Biopharmaceutical Cold Chain Logistics Price (USD/Unit), by Type (2019-2020)
3.3.4 Sales in USA Market, by Type (2026-2027)3.4 Japan Biopharmaceutical Cold Chain Logistics Market
3.4.1 Top Companies leading Biopharmaceutical Cold Chain Logistics Development in Japan (2016-2021)
3.4.2 Sales Value of Major Company in Japan Market (2016-2021)
3.4.3 Japan Biopharmaceutical Cold Chain Logistics Price (USD/Unit), by Type (2019-2020)
3.4.4 Sales in Japan Market, by Type (2026-2027)3.5 India Biopharmaceutical Cold Chain Logistics Market
3.5.1 Top Companies leading Biopharmaceutical Cold Chain Logistics Development in India (2016-2021)
3.5.2 Sales Value of Major Company in India Market (2016-2021)
3.5.3 India Biopharmaceutical Cold Chain Logistics Price (USD/Unit), by Type (2019-2020)
3.5.4 Sales in India Market, by Type (2026-2027)3.6 Southeast Asia Biopharmaceutical Cold Chain Logistics Market
3.6.1 Top Companies leading Biopharmaceutical Cold Chain Logistics Development in Southeast Asia (2016-2021)
3.6.2 Sales Value of Major Company in Southeast Asia Market (2016-2021)
3.6.3 Southeast Asia Biopharmaceutical Cold Chain Logistics Price (USD/Unit), by Type (2019-2020)
3.6.4 Sales in Southeast Asia Market, by Type (2026-2027)
3.7 South America Biopharmaceutical Cold Chain Logistics Market
3.7.1 Top Companies leading Biopharmaceutical Cold Chain Logistics Development in South America (2016-2021)
3.7.2 Sales Value of Major Company in South America Market (2016-2021)
3.7.3 South America Biopharmaceutical Cold Chain Logistics Price (USD/Unit), by Type (2019-2020)
3.7.4 Sales in South America Market, by Type (2026-2027)
4 Value Chain (Impact of COVID-19)4.1 Biopharmaceutical Cold Chain Logistics Value Chain Analysis
4.1.1 Upstream
4.1.2 Downstream4.2 COVID-19 Impact on Biopharmaceutical Cold Chain Logistics Industry
4.2.1 Industrial Policy Issued Under the Epidemic Situation4.3 Cost-Under the Epidemic Situation
4.3.1 Cost of Raw Material4.4 Channel Analysis
4.4.1 Distribution Channel-Under the Epidemic Situation
4.4.2 Distributors
5 Regional Market Forecast (2021-2027)5.1 Global Biopharmaceutical Cold Chain Logistics Sales and Growth Rate (2021-2027)
5.2 Global Biopharmaceutical Cold Chain Logistics Sales Value and Growth Rate (2021-2027)
6 Biopharmaceutical Cold Chain Logistics Competitive Analysis6.1 Agility Logistics
6.1.1 Agility Logistics Company Profiles
6.1.2 Agility Logistics Product Introduction
6.1.3 Agility Logistics Biopharmaceutical Cold Chain Logistics Production, Revenue (2016-2021)
6.1.4 SWOT Analysis6.2 Deutsche Post
6.2.1 Deutsche Post Company Profiles
6.2.2 Deutsche Post Product Introduction
6.2.3 Deutsche Post Biopharmaceutical Cold Chain Logistics Production, Revenue (2016-2021)
6.2.4 SWOT Analysis6.3 FedEx
6.3.1 FedEx Company Profiles
6.3.2 FedEx Product Introduction
6.3.3 FedEx Biopharmaceutical Cold Chain Logistics Production, Revenue (2016-2021)
6.3.4 SWOT Analysis6.4 JWD InfoLogistics Public
6.4.1 JWD InfoLogistics Public Company Profiles
6.4.2 JWD InfoLogistics Public Product Introduction
6.4.3 JWD InfoLogistics Public Biopharmaceutical Cold Chain Logistics Production, Revenue (2016-2021)
6.4.4 SWOT Analysis6.5 Kerry Logistics Network
6.5.1 Kerry Logistics Network Company Profiles
6.5.2 Kerry Logistics Network Product Introduction
6.5.3 Kerry Logistics Network Biopharmaceutical Cold Chain Logistics Production, Revenue (2016-2021)
6.5.4 SWOT Analysis
7 Conclusion
-
The (Post pandemic Era) Global Biopharmaceutical Cold Chain Logistics Market has been segregated into various crucial divisions including applications, types, and regions. Each market segment is intensively studied in the report contemplating its market acceptance, worthiness, demand, and growth prospects. The segmentation analysis will help the client to customize their marketing approach to have a better command of each segment and to identify the most prospective customer base.
Report Objectives / Segmentation Covered :
By Companies / players:
By Regions:
By Type:
By Application:
Frequently asked questions(FAQ's):
The (Post pandemic Era) Global Biopharmaceutical Cold Chain Logistics study includes a diverse group of participants, including both market leaders and up-and-comers. Contact our sales representative to receive a complete list of companies covered in the study.
During the projected year from 2025 to 2030, the (Post pandemic Era) Global Biopharmaceutical Cold Chain Logistics Market is expected to grow at a CAGR of xx%.
The influx of capital into the (Post pandemic Era) Global Biopharmaceutical Cold Chain Logistics Market, as well as the deployment of technologies designed to increase efficiency and yield high volume, are paving the way for promising market opportunities.
The latest version of the (Post pandemic Era) Global Biopharmaceutical Cold Chain Logistics Market study includes a market size breakdown by relevant business segments, applications, and geography, as well as qualitative insights such as Patent Analysis*, Market Entropy, Key Development Activities, Market Dynamics, PEST and PORTER models, and more.
